POSITIVE EFFECTS OF SH2 DOMAIN-CONTAINING TYROSINE PHOSPHATASE SHP-1 ON EPIDERMAL GROWTH FACTOR-STIMULATED AND INTERFERON-GAMMA-STIMULATED ACTIVATION OF STAT TRANSCRIPTION FACTORS IN HELA-CELLS

Authors
Citation
M. You et Zz. Zhao, POSITIVE EFFECTS OF SH2 DOMAIN-CONTAINING TYROSINE PHOSPHATASE SHP-1 ON EPIDERMAL GROWTH FACTOR-STIMULATED AND INTERFERON-GAMMA-STIMULATED ACTIVATION OF STAT TRANSCRIPTION FACTORS IN HELA-CELLS, The Journal of biological chemistry, 272(37), 1997, pp. 23376-23381
Citations number
36
Categorie Soggetti
Biology
ISSN journal
00219258
Volume
272
Issue
37
Year of publication
1997
Pages
23376 - 23381
Database
ISI
SICI code
0021-9258(1997)272:37<23376:PEOSDT>2.0.ZU;2-4
Abstract
SHP-1 (also known as PTP1C, SHPTP-1, SHP, and HCP) is an SH2 domain-co ntaining protein-tyrosine phosphatase. We have stably overexpressed th e native form and a catalytically inactive cysteine to serine mutant o f the enzyme, SHP-1-(Cys --> Ser), in human cervical carcinoma HeLa ce lls, Following stimulation of the cells with epidermal growth factor ( EGF) and interferon-gamma (INF-gamma), signal transducers and activato rs of transcription (STAT) activity was analyzed by using two P-32-lab eled DNA probes, namely hSIE which is derived from a high affinity mut ant form of the serum-inducible element in the c-fos promotor and GAS which resembles the INF-gamma activation site, EGF induced hSIE bindin g activity only, and the activity was suppressed by similar to 70% whe n the inactive mutant. form of SHP-1 was expressed but was essentially unaffected by expression of the native enzyme. INF-gamma treatment re sulted in appearance of both hSIE and GAS binding activities. While ex pression of the inactive mutant reduced the activities by 30-50%, the native enzyme caused a 20-30% increase. Consistent with effects on STA T activation, altered SHP-1 expression also affected EGF-induced activ ation of the mitogen-activated protein kinase pathway; expression of S HP-1-(Cys --> Ser) inhibited activity of MEK by similar to 25%, wherea s expression of SHP-1 resulted in a similar to 25% increase. Further s tudies revealed that overexpression of SHP-1 caused decreased tyrosine phosphorylation of the EGF receptor and that EGF induced phosphorylat ion and recruitment of SHP-1. Together, the data suggest that SHP-1 is positively involved in EGF-and INF-gamma-induced STAT activation in n on-hematopoietic HeLa cells and that, in the EGF signaling system, SHP -1 functions at least partly by modulating tyrosine phosphorylation of EGF receptor.